On ECHEMI
Home > Drugs > Empagliflozin Registered Holders
Empagliflozin structure

Empagliflozin structure

Empagliflozin

Empagliflozin is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2.

Find 81 Related Holders

AZICO BIOPHORE INDIA PRIVATE LTD
United States United States

API Registration Country

API Active
MANKIND PHARMA LTD
United States United States

API Registration Country

API Active
METROCHEM API PRIVATE LTD
United States United States

API Registration Country

API Active
MSN LIFE SCIENCES PRIVATE LTD
United States United States

API Registration Country

API Active
OPTIMUS DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
HONOUR LAB LTD
United States United States

API Registration Country

API Active
LEE PHARMA LTD
United States United States

API Registration Country

API Active
AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)
United States United States

API Registration Country

API Active
LAURUS LABS LTD
United States United States

API Registration Country

API Active
LUPIN MANUFACTURING SOLUTIONS LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Empagliflozin
View 138 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.